Debu Tripathy, MD, MD Anderson Cancer Center
Advertisement
Articles by Debu Tripathy, MD, MD Anderson Cancer Center
Advertisement
Latest Updated Articles
Prognostic Tools for Early-Stage HER2+ Breast CancerPublished: January 25th 2021 | Updated:
Current Treatment Landscape for HER2+ Breast CancerPublished: January 25th 2021 | Updated:
Updated Data for Metastatic HER2+ Breast CancerPublished: January 25th 2021 | Updated:
Advertisement
Advertisement
Trending on OncLive
1
Long-Term Cilta-Cel Data Show Low Rates of PFS Events in Standard-Risk R/R Myeloma
2
Real-World Data Support Clinical Benefit With Lifileucel in Previously Treated Advanced Melanoma
3
FDA Updates Axi-Cel Label to Remove Limitation of Use in R/R PCNSL
4
Dr Riedell on the Long-Term Efficacy of Tisa-Cel in R/R Follicular Lymphoma
5